These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16162699)

  • 1. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma.
    Jang AS; Lee JH; Park SW; Lee YM; Uh ST; Kim YH; Park CS
    Chest; 2005 Sep; 128(3):1140-5. PubMed ID: 16162699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma.
    Choi JS; Jang AS; Lee JH; Park JS; Park SW; Kim DJ; Park CS
    J Korean Med Sci; 2005 Aug; 20(4):586-90. PubMed ID: 16100448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
    Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
    Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.
    Schuh S; Reisman J; Alshehri M; Dupuis A; Corey M; Arseneault R; Alothman G; Tennis O; Canny G
    N Engl J Med; 2000 Sep; 343(10):689-94. PubMed ID: 10974132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.
    Foresi A; Mastropasqua B; Chetta A; D'Ippolito R; Testi R; Olivieri D; Pelucchi A
    Chest; 2005 Jan; 127(1):117-24. PubMed ID: 15653971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.
    Nimmagadda SR; Spahn JD; Nelson HS; Jenkins J; Szefler SJ; Leung DY
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
    Dahl R; Nielsen LP; Kips J; Foresi A; Cauwenberge P; Tudoric N; Howarth P; Richards DH; Williams M; Pauwels R;
    Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.